Literature DB >> 18478592

Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene.

Edmund C Jenkins1, Flora Tassone, Lingling Ye, Hong Gu, Man Xi, Milen Velinov, W Ted Brown, Randi J Hagerman, Paul J Hagerman.   

Abstract

Reduced telomere length has recently been reported in T lymphocytes of individuals with trisomy 21 Down syndrome (DS) and dementia. Shorter telomeres also have been documented in dyskeratosis congenita, cell senescence, Alzheimer disease, and neoplastic transformation. These observations suggest that similar shortening may occur in people with fragile X-associated tremor/ataxia syndrome (FXTAS), which frequently is accompanied by dementia. To test this hypothesis, telomere length has been quantified in T lymphocytes from older male carriers of premutation FMR1 alleles, with or without FXTAS, and FXTAS with dementia. Shorter telomeres (relative to age-matched controls) were observed in 5/5 individuals with FXTAS and dementia, in 2/2 individuals with FXTAS without dementia, and in 3/3 individuals with the fragile X premutation only (P values ranged from <0.001 to <0.05; Student's t-test), indicating that telomere shortening is associated with the premutation expansion of the FMR1 gene. The current study design allowed simultaneous comparisons among control, premutation, FXTAS, and FXTAS with dementia samples, and showed nearly equal degrees of shortening relative to controls among the three premutation sample groups. Thus, telomere shortening may serve as a biomarker for cellular dysregulation that may precede the development of the symptoms of FXTAS. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478592      PMCID: PMC2766597          DOI: 10.1002/ajmg.a.32342

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  Quantifying telomere lengths of human individual chromosome arms by centromere-calibrated fluorescence in situ hybridization and digital imaging.

Authors:  Sven Perner; Silke Brüderlein; Cornelia Hasel; Irena Waibel; Alexandra Holdenried; Neslisah Ciloglu; Heiko Chopurian; Kirsten Vang Nielsen; Andreas Plesch; Josef Högel; Peter Möller
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

2.  Telomere shortening in T cells correlates with Alzheimer's disease status.

Authors:  L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

3.  Does a sentinel or a subset of short telomeres determine replicative senescence?

Authors:  Ying Zou; Agnel Sfeir; Sergei M Gryaznov; Jerry W Shay; Woodring E Wright
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

4.  Heterogeneity in telomere length of human chromosomes.

Authors:  P M Lansdorp; N P Verwoerd; F M van de Rijke; V Dragowska; M T Little; R W Dirks; A K Raap; H J Tanke
Journal:  Hum Mol Genet       Date:  1996-05       Impact factor: 6.150

5.  Differences in telomere length between homologous chromosomes in humans.

Authors:  J A Londoño-Vallejo; H DerSarkissian; L Cazes; G Thomas
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

6.  Telomere reduction in human colorectal carcinoma and with ageing.

Authors:  N D Hastie; M Dempster; M G Dunlop; A M Thompson; D K Green; R C Allshire
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

7.  Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  Nat Cell Biol       Date:  2007-12-23       Impact factor: 28.824

8.  Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects.

Authors:  Athanase Benetos; Jeffrey P Gardner; Mahmoud Zureik; Carlos Labat; Lu Xiaobin; Chris Adamopoulos; Mohamed Temmar; Kathryn E Bean; Frédérique Thomas; Abraham Aviv
Journal:  Hypertension       Date:  2004-01-19       Impact factor: 10.190

9.  In vivo loss of telomeric repeats with age in humans.

Authors:  J Lindsey; N I McGill; L A Lindsey; D K Green; H J Cooke
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

10.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025

View more
  10 in total

1.  Telomere shortening in Down syndrome patients--when does it start?

Authors:  Aleksandra Gruszecka; Przemysław Kopczyński; Dorota Cudziło; Natalia Lipińska; Aleksandra Romaniuk; Wojciech Barczak; Natalia Rozwadowska; Ewa Totoń; Błażej Rubiś
Journal:  DNA Cell Biol       Date:  2015-03-18       Impact factor: 3.311

Review 2.  Advances in understanding the molecular basis of FXTAS.

Authors:  Dolores Garcia-Arocena; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2010-04-29       Impact factor: 6.150

3.  Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Andreea L Seritan; Kyoungmi Kim; Ian Benjamin; Ioana Seritan; Randi J Hagerman
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-09-21       Impact factor: 2.680

4.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

5.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

6.  CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS.

Authors:  Gry Hoem; Christopher R Raske; Dolores Garcia-Arocena; Flora Tassone; Eleonora Sanchez; Anna L Ludwig; Christine K Iwahashi; Madhur Kumar; Jane E Yang; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2011-03-09       Impact factor: 6.150

7.  Reduced telomere length in individuals with FMR1 premutations and full mutations.

Authors:  Edmund C Jenkins; Flora Tassone; Lingling Ye; André T Hoogeveen; W Ted Brown; Randi J Hagerman; Paul J Hagerman
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

8.  A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.

Authors:  Roman Alpatov; Bluma J Lesch; Mika Nakamoto-Kinoshita; Andres Blanco; Shuzhen Chen; Alexandra Stützer; Karim J Armache; Matthew D Simon; Chao Xu; Muzaffar Ali; Jernej Murn; Sladjana Prisic; Tatiana G Kutateladze; Christopher R Vakoc; Jinrong Min; Robert E Kingston; Wolfgang Fischle; Stephen T Warren; David C Page; Yang Shi
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

Review 9.  Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Robert F Berman; Ronald Am Buijsen; Karen Usdin; Elizabeth Pintado; Frank Kooy; Dalyir Pretto; Isaac N Pessah; David L Nelson; Zachary Zalewski; Nicholas Charlet-Bergeurand; Rob Willemsen; Renate K Hukema
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

10.  Current Gaps in Understanding the Molecular Basis of FXTAS.

Authors:  Paul J Hagerman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.